Onesource Specialty Pharma quarterly resultsNext results date, and the last two years

Next results · July–September 2026
Tuesday, 27 October 2026
In 4 days

The board meets to approve the quarter's results. Onesource Specialty Pharma told NSE on Wednesday, 21 October.

Get an email before Onesource Specialty Pharma reports

Up to three days before, and on the day with the results as soon as they're filed.

Not investment advice

Dates come from Onesource Specialty Pharma's filings on NSE and can change until the meeting happens. This is information, not a recommendation to buy or sell. Stockport is not a SEBI-registered investment adviser.

Source: NSE · updated 23 Oct, 09:05 IST

Over the last 8 quarters on file, Onesource Specialty Pharma published its results 23 to 133 days after each quarter ended. Its July–September results came on 11 November 2025 and 10 February 2025.

Past results dates

NSE ONESOURCE
QuarterPeriodResults filedDays after quarter endResults
Q2 FY27Jul–Sep 2026Tue 27 Oct 2026Upcoming27
Q1 FY27Apr–Jun 2026Fri 24 Jul 202624Read
Q4 FY26Jan–Mar 2026Wed 13 May 202643Read
Q3 FY26Oct–Dec 2025Fri 23 Jan 202623Read
Q2 FY26Jul–Sep 2025Tue 11 Nov 202542Read
Q1 FY26Apr–Jun 2025Mon 4 Aug 202535Read
Q4 FY25Jan–Mar 2025Mon 5 May 202535Read
Q3 FY25Oct–Dec 2024Wed 29 Jan 202529Read
Q2 FY25Jul–Sep 2024Mon 10 Feb 2025133Read

Never miss a results day on your stocks

Stockport is an investment research journal for serious investors. It makes your thesis actionable by reading out claims from your raw notes and keeping score against them.

Try Stockport free
Read before results day

Questions about Onesource Specialty Pharma's results

When will Onesource Specialty Pharma announce its July–September 2026 results?

On Tuesday, 27 October 2026, at its board meeting, according to the company's filing with NSE on 21 October.

Where can I read Onesource Specialty Pharma's results?

Once the company files them with NSE, a link appears on this page next to the quarter. The last eight quarters' filings are linked in the table above.